Background & Aims: Although the discriminative ability of the model for end-stage liver disease (MELD) score is generally considered acceptable, its calibration is still unclear. In a validation study, we assessed the discriminative performance and calibration of 3 versions of the model: original MELD-TIPS, used to predict survival after transjugular intrahepatic portosystemic shunt (TIPS); classic MELD-Mayo; and MELD-UNOS, used by the United Network for Organ Sharing (UNOS). We also explored recalibrating and updating the model.Methods: In total, 776 patients who underwent elective TIPS (TIPS cohort) and 445 unselected patients (non-TIPS cohort) were included. Three, 6 and 12-month mortality predictions were calculated by the 3 MELD versions: discrimination was assessed by c-statistics and calibration by comparing deciles of predicted and observed risks. Cox and Fine and Grey models were used for recalibration and prognostic analyses.Results: In the TIPS/non-TIPS cohorts, the etiology of liver disease was viral in 402/188, alcoholic in 185/130, and nonalcoholic steatohepatitis in 65/33; mean follow-up +/- SD was 25 +/- 9/19 +/- 21 months; and the number of deaths at 3-6-12 months was 57-102-142/31-47-99, respectively. C-statistics ranged from 0.66 to 0.72 in TIPS and 0.66 to 0.76 in non-TIPS cohorts across prediction times and scores. A post hoc analysis revealed worse c-statistics in non-viral cirrhosis with more pronounced and significant worsening in the non-TIPS cohort. Calibration was acceptable with MELD-TIPS but largely unsatisfactory with MELD-Mayo and-UNOS whose performance improved much after recalibration. A prognostic analysis showed that age, albumin, and TIPS indication might be used to update the MELD.Conclusions: In this validation study, the performance of the MELD score was largely unsatisfactory, particularly in non-viral cirrhosis. MELD recalibration and candidate variables for an update to the MELD score are proposed.Lay summary: While the discriminative performance of the model for end-stage liver disease (MELD) score is credited to be fair to good, its calibration, the correspondence of observed to predicted mortality, is still unsettled. We found that application of 3 different versions of the MELD in 2 independent cirrhosis cohorts yielded largely imprecise mortality predictions particu-larly in non-viral cirrhosis. Thus, we propose a recalibration and suggest candidate variables for an update to the model. (C) 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Performance of the model for end-stage liver disease score for mortality prediction and the potential role of etiology / D'Amico, Gennaro; Maruzzelli, Luigi; Airoldi, Aldo; Petridis, Ioannis; Tosetti, Giulia; Rampoldi, Antonio; D'Amico, Mario; Miraglia, Roberto; De Nicola, Stella; La Mura, Vincenzo; Solcia, Marco; Volpes, Riccardo; Perricone, Giovanni; Sgrazzutti, Cristiano; Vanzulli, Angelo; Primignani, Massimo; Luca, Angelo; Malizia, Giuseppe; Federico, Alessandro; Dallio, Marcello; Andriulli, Angelo; Iacobellis, Angelo; Addario, Luigi; Garcovich, Matteo; Gasbarrini, Antonio; Chessa, Luchino; Salerno, Francesco; Gobbo, Giulia; Merli, Manuela; Ridola, Lorenzo; Baroni, Gianluca Svegliati; Tarantino, Giuseppe; Caporaso, Nicola; Morisco, Filomena; Pozzoni, Pietro; Colli, Agostino; Belli, Luca Saverio. - In: JOURNAL OF HEPATOLOGY. - ISSN 0168-8278. - 75:6(2021), pp. 1355-1366. [10.1016/j.jhep.2021.07.018]

Performance of the model for end-stage liver disease score for mortality prediction and the potential role of etiology

D'Amico, Mario;Baroni, Gianluca Svegliati;Tarantino, Giuseppe;
2021-01-01

Abstract

Background & Aims: Although the discriminative ability of the model for end-stage liver disease (MELD) score is generally considered acceptable, its calibration is still unclear. In a validation study, we assessed the discriminative performance and calibration of 3 versions of the model: original MELD-TIPS, used to predict survival after transjugular intrahepatic portosystemic shunt (TIPS); classic MELD-Mayo; and MELD-UNOS, used by the United Network for Organ Sharing (UNOS). We also explored recalibrating and updating the model.Methods: In total, 776 patients who underwent elective TIPS (TIPS cohort) and 445 unselected patients (non-TIPS cohort) were included. Three, 6 and 12-month mortality predictions were calculated by the 3 MELD versions: discrimination was assessed by c-statistics and calibration by comparing deciles of predicted and observed risks. Cox and Fine and Grey models were used for recalibration and prognostic analyses.Results: In the TIPS/non-TIPS cohorts, the etiology of liver disease was viral in 402/188, alcoholic in 185/130, and nonalcoholic steatohepatitis in 65/33; mean follow-up +/- SD was 25 +/- 9/19 +/- 21 months; and the number of deaths at 3-6-12 months was 57-102-142/31-47-99, respectively. C-statistics ranged from 0.66 to 0.72 in TIPS and 0.66 to 0.76 in non-TIPS cohorts across prediction times and scores. A post hoc analysis revealed worse c-statistics in non-viral cirrhosis with more pronounced and significant worsening in the non-TIPS cohort. Calibration was acceptable with MELD-TIPS but largely unsatisfactory with MELD-Mayo and-UNOS whose performance improved much after recalibration. A prognostic analysis showed that age, albumin, and TIPS indication might be used to update the MELD.Conclusions: In this validation study, the performance of the MELD score was largely unsatisfactory, particularly in non-viral cirrhosis. MELD recalibration and candidate variables for an update to the MELD score are proposed.Lay summary: While the discriminative performance of the model for end-stage liver disease (MELD) score is credited to be fair to good, its calibration, the correspondence of observed to predicted mortality, is still unsettled. We found that application of 3 different versions of the MELD in 2 independent cirrhosis cohorts yielded largely imprecise mortality predictions particu-larly in non-viral cirrhosis. Thus, we propose a recalibration and suggest candidate variables for an update to the model. (C) 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
2021
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11566/316571
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 17
social impact